These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2102750)

  • 21. [An open comparative study of captopril + hydrochlorothiazide versus chlorthalidone for the treatment of mild and moderate primary hypertension].
    Franco RJ; Sampaio M; Balbi AL; Martin LC; Luna RL
    Arq Bras Cardiol; 1992 Nov; 59(5):423-7. PubMed ID: 1340743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
    Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined clonidine-chlorthalidone therapy in hypertension. Two years' experience in 30 patients.
    Rosenman RH
    Arch Intern Med; 1975 Sep; 135(9):1236-9. PubMed ID: 1164125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of fixed combinations of saluretic agents and potassium in sustained release form for the treatment of arterial hypertension.
    Jäättelä A
    Eur J Clin Pharmacol; 1972 Jun; 4(3):146-9. PubMed ID: 4655289
    [No Abstract]   [Full Text] [Related]  

  • 26. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Bravo EL; Krakoff LR; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamics of the hemostasis parameters in patients with arterial hypertension in treatment with combined antihypertensive agents].
    Zaremba IeKh; Bula MS; Zaremba-Fedchyshyn OV; Zaremba OV; Virna MM
    Wiad Lek; 2014; 67(2 Pt 2):328-31. PubMed ID: 25796861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
    Shamiss A; Meisel S; Nussinovitch N; Rosenthal T
    J Hum Hypertens; 1990 Aug; 4(4):465-8. PubMed ID: 2258895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension and arrhythmias: effects of slow-release nicardipine vs chlorthalidone: a double-blind crossover study.
    Galderisi M; Celentano A; Tammaro P; Garofalo M; Mureddu GF; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):410-5. PubMed ID: 2258249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension.
    Tuomilehto J; Puska P; Mustaniemi H
    Acta Med Scand Suppl; 1974; 554():47-54. PubMed ID: 4593673
    [No Abstract]   [Full Text] [Related]  

  • 34. New sustained-release nifedipine formulation in treatment of essential hypertension. Unidipin Cooperative Study Group.
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):349-53. PubMed ID: 1378112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison between amlodipine and nifedipine retard in patients with essential arterial hypertension].
    Terrachini V; Canale C; Lonati A; Masperone MA; Bruzzone F; Malvestiti FM; Caponnetto S
    Clin Ter; 1992 Apr; 140(4):383-9. PubMed ID: 1534044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.
    Matthews KA; Brenner MJ; Brenner AC
    Clin Ther; 2013 Sep; 35(9):1423-30. PubMed ID: 23993697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension].
    Hergueta García de Guadiana G; Paumard Fraguas A
    An Med Interna; 1989 Jan; 6(1):15-8. PubMed ID: 2491026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.